(Q42698615)

English

Agglomerate strength and dispersion of salmeterol xinafoate from powder mixtures for inhalation

scientific article published on 14 September 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Agglomerate strength and dispersion of salmeterol xinafoate from powder mixtures for inhalation (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

author name string

Handoko Adi

1

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Ian Larson

2

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Herbert Chiou

3

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Paul Young

4

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Peter Stewart

6

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

publication date

14 September 2006

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Pharmaceutical Research

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

2556-2565

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Influence of physico-chemical carrier properties on the in vitro aerosol deposition from interactive mixtures

1 reference

https://pubmed.ncbi.nlm.nih.gov/16972185

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Protein deposition from dry powder inhalers: fine particle multiplets as performance modifiers

1 reference

https://pubmed.ncbi.nlm.nih.gov/16972185

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Particle interactions involved in aerosol dispersion of ternary interactive mixtures

1 reference

https://pubmed.ncbi.nlm.nih.gov/16972185

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lactose surface modification by decantation: are drug-fine lactose ratios the key to better dispersion of salmeterol xinafoate from lactose-interactive mixtures?

1 reference

https://pubmed.ncbi.nlm.nih.gov/16972185

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The influence of lactose carrier on the content homogeneity and dispersibility of beclomethasone dipropionate from dry powder aerosols

1 reference

https://pubmed.ncbi.nlm.nih.gov/16972185

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of carrier size on the dispersion of salmeterol xinafoate from interactive mixtures

1 reference

https://pubmed.ncbi.nlm.nih.gov/16972185

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11095-006-9082-6

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42698615&oldid=1966292288"